|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/22 | (2006.01) |
| C07K 16/28 | (2006.01) | ||
| C07K 16/30 | (2006.01) | ||
| C07K 16/40 | (2006.01) | ||
| A61K 39/00 | (2006.01) |
| (11) | Number of the document | 2356153 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09783664.7 |
| Date of filing the European patent application | 2009-10-01 | |
| (97) | Date of publication of the European application | 2011-08-17 |
| (45) | Date of publication and mention of the grant of the patent | 2016-05-04 |
| (46) | Date of publication of the claims translation | 2016-08-10 |
| (86) | Number | PCT/EP2009/062793 |
| Date | 2009-10-01 |
| (87) | Number | WO 2010/037836 |
| Date | 2010-04-08 |
| (30) | Number | Date | Country code |
| 101857 P | 2008-10-01 | US |
| (72) |
KUFER, Peter, DE
RAUM, Tobias, DE
KISCHEL, Roman, DE
LUTTERBÜSE, Ralf, DE
HOFFMANN, Patrick, DE
RAU, Doris, DE
MANGOLD, Susanne, DE
KLINGER, Matthias, DE
SCHALLER, Evelyne, DE
HAUSMANN, Susanne, DE
FLUHR, Petra, DE
STEIGER, Carola, DE
|
| (73) |
Amgen Research (Munich) GmbH,
Staffelseestrasse 2, 81477 München,
DE
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Tarprūšinis specifinis PSMAxCD3 bispecifinis viengrandis antikūnas |
| CROSS-SPECIES-SPECIFIC PSMAXCD3 BISPECIFIC SINGLE CHAIN ANTIBODY |
| Payment date | Validity (years) | Amount | |
| 2024-09-19 | 16 | 347.00 EUR |
| 2025-10-01 |